Tag Archives: cannabis

Cannabis, Marijuana, Weed, Pot? Just Call It a Job Machine

SAN FRANCISCO — David Dancer is a 48-year-old marketing executive who has worked for big brands like Charles Schwab and Teleflora. A year ago, he got a call from a recruiter for a different kind of company: MedMen, a cannabis retailer that has been called “the Apple Store of weed.” The opening was for a chief marketing officer. He took it.

One of Mr. Dancer’s early projects was a slick two-minute video by the director Spike Jonze that begins with an anecdote about George Washington as a hemp grower, a staple of dorm-room conversation. It concludes with a suburban couple coming home with a bright red bag of legally purchased pot, symbolizing “the new normal” — an ending that, like his own career twist, seemed improbable not long ago.

To read more…

Congressional Democrats Focus Heavily on Cannabis Reform

For the first time ever, congressional democrats included a panel at their policy retreat that was focused entirely on cannabis reform.
Last Thursday morning was the panel at the House Democrats’ gathering, with cannabis advocates sharing their point of view on why reform is not only a necessity in this day and age, but also how a new system should be implemented. It was titled “From the War on Drugs to Restorative Justice: Ensuring Racial and Social Equity in the Cannabis Movement,” and was quite busy despite an early, 7:45 am start time.

Overall, conversations weren’t centered on whether to end prohibition or not – which seemed to go without saying as an already accepted conclusion – but rather how to shape the legal industry moving forward. Also discussed was the need to repair past harms caused by the ongoing “war on drugs”. There was a great deal of significance put on the racial injustices of prohibition.

To read more…

Insights on marijuana and opioid use in people with cancer

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study also found that patients with cancer are more likely to use prescription opioids than adults without cancer.

Pain is a common symptom of cancer, and many affected patients do not receive adequate pain relief. In light of rapidly evolving marijuana legislation and a growing opioid epidemic, a team led by Jona Hattangadi-Gluth, MD, and Kathryn Ries Tringale, MD, MAS, of the University of California, San Diego, examined trends in the self-disclosed use of marijuana and opioids among patients with cancer.

To read more…

Shoppers Drug Mart launches second online medical pot portal in Alberta

TORONTO — Medical cannabis users in Alberta can now get their therapeutic pot from Shoppers Drug Mart, with the retail giant opening its second online platform Tuesday in the western province as it pursues the growing market.

The launch follows the January debut of Medical Cannabis by Shoppers Drug Mart in Ontario, where the company says uptake “has been strong.”

As in Ontario, the Alberta platform touts “expert advice and counsel from trusted health-care professionals,” including tips on the purported health properties of various strains, proper dosages and titration techniques.

To read more…

Navigating the New World of Marijuana

The marijuana market has grown substantially over the course of the past few years. With so much growth and new legislation occurring around North America and in select countries abroad, it seems as though it can be difficult at times to navigate the tricky obstacles of buying and using cannabis. So here is a small beginners guide to the sticky world of cannabis.

The first thing one should note before walking into that tempting dispensary is the different kinds of cannabis available. The three main types are sativa, indica and a hybrid of both. These three types of weed all have varying uses, but they all do serve a solid purpose as cannabis.

Sativa is known widely as the uplifting daytime cannabis. The main characteristics of this type are that it provides a very useable strain selection based in being able to function throughout the day without falling asleep. Indica, on the other hand, does quite the opposite. Strains categorized as Indica have the potential to make the user sleepy and are not suggested for daytime use, but this has been noted as one of the desirable effects of the type.

To read more…

The Marijuana Stock Market Is Beginning to Mature as Time Goes On

The marijuana stock market has begun to move out of its infancy which is characterized by the shift toward stability we have seen over the past few months. In that time, many companies have begun to stabilize in terms of their pricing which has led more investors to come in than ever before. This is not to say that the industry is without its volatility as one may have noticed in the past few weeks. Despite this, some companies have moved toward finding their sweet spot as we move into the future of the market.

Biome Grow Inc. (BIOIF/BIO.CN) is a company that operates out of a large range of subsidiaries all under the Biome Grow name. The company currently has subsidiaries across Canada in Newfoundland and Labrador, Ontario, Nova Scotia, Prince Edward Island and is looking to move into more domestic markets. The company works in various sectors of the cannabis industry but has mainly been focused on the production of cannabis as well as the technology of the new recreational market.

To read more…

Cannabis is now a commodity, but commercial realities are kicking in

Colorado opened the world’s first regulated recreational marijuana marketin 2014. That’s some five years ago.

A lot has changed since then, with regulations now extending to global markets and businesses opening up, on what seems to be almost a weekly basis.

According to Mark Bernberg of the Greenfund, “the global cannabis market is thought to be worth US$150 billion today. Barclays, in their European Consumer Staples Report in September 2018, suggests that this figure could increase to US$272 billion by 2028.

Clearly, cannabis is now a growing legal commodity and that means proper business practices need to be put in place.

To read more…

The Key to Success for California Cannabis Businesses – Managing Tax Liabilities

The key to the long-term success of every medical or adult-use cannabis business in California will be found in the management of tax liabilities. The usual reasons for long-term success in business – creativity, perseverance, experience, business acumen and connections – are important. The management of the direct and indirect impact of the multiple taxes to which California cannabis businesses are subject, and the preparation and maintenance of the financial records required for the management of these tax liabilities, will, however, prove to be the single most important factor in the success of a California cannabis business in the long-term.

Do not stop reading this article based on the premise the above statement does not apply to you because you are a well-established cultivator and the bulk of the taxes on cannabis apply to dispensaries and distributors. Taxes impact the amount a cultivator will receive. All of the money that various governmental agencies take out of California’s cannabis industry is not available to pay costs and to provide profits. Cultivators, distributors and dispensaries must split the money that is left after all of the taxes on cannabis are paid.

To read more…

Why Synthetic CBD Is (Probably) the Future of Cannabis Pharma

While there is a race among cannabis cultivators to have the largest greenhouse in the world, the race is on for medical cannabis biotechs to create a synthetic form of CBD, one that is not derived from the cannabis plant, but cooked up in a lab.

Greenhouses packed with those verdant, pungent plants could become relics of the past, because if you’re a medical cannabis patient, it’s not the plant that you need, it’s the cannabinoids — and both THC and CBD can be synthesized. For medical marijuana pharmaceutical companies, synthetic cannabinoids could cut massive costs of growing the plant and quicken the FDA approval process. The first company to create and patent a CBD compound would command a serious edge in this fast-growing industry.

To read more…

Cannabis companies say they are growing enough pot, they just can’t deliver it

One pesky stamp has become the symbol of a continuing problem in Canada: Pot producers struggling to get enough cannabis to market, at least in the ways that buyers want it.

Pot producers had to scramble to apply the required excise-tax stamps with no glue as legalization kicked off last October, and many are still having to apply them by hand to some packages months later as supply issues continue. While Organigram OGI, +4.86% OGRMF, +3.77%  has figured out how to automate its production of some products, the Moncton, New Brunswick-based company still must manually apply the tax stamps onto its raw-marijuana containers, Chief Executive Greg Engel told MarketWatch in an interview Monday.

To read more…